Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) Shares Outstanding (2016 - 2025)

InspireMD (NSPR) has 14 years of Shares Outstanding data on record, last reported at $41.9 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 2439896.57% year-over-year to $41.9 million; the TTM value through Sep 2025 reached $41.9 million, up 2439896.57%, while the annual FY2024 figure was $1718.0, 0.0% changed from the prior year.
  • Shares Outstanding reached $41.9 million in Q3 2025 per NSPR's latest filing, up from $1718.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $41.9 million in Q3 2025 and bottomed at $1718.0 in Q3 2021.
  • Average Shares Outstanding over 5 years is $8.2 million, with a median of $1718.0 recorded in 2021.
  • Peak YoY movement for Shares Outstanding: crashed 99.98% in 2023, then skyrocketed 2439896.57% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $8.3 million in 2021, then tumbled by 99.98% to $1718.0 in 2022, then changed by 0.0% to $1718.0 in 2023, then changed by 0.0% to $1718.0 in 2024, then surged by 2439896.57% to $41.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $41.9 million in Q3 2025, $1718.0 in Q2 2025, and $1718.0 in Q1 2025.